Evolution Devices, Inc.

Evolution Devices, Inc. manufactures EvoWalk, an FDA-cleared wearable Functional Electrical Stimulation (FES) device designed to improve walking ability and mobility in patients with foot drop caused by neurological impairments. The device stimulates leg muscles (tibialis anterior, hamstring, and knee flexors/extensors) at precise moments during the gait cycle to enhance ankle dorsiflexion, reduce tripping, and increase overall gait stability. EvoWalk incorporates advanced AI algorithms that learn individual walking patterns and personalize stimulation delivery in real time. The system includes a slim, wearable controller and a companion mobile app for adjusting stimulation levels, setting therapy goals, and tracking mobility metrics including steps, speed, and distance. Clinical evidence shows users achieve approximately 30% more steps and 15% faster walking speed after three months of consistent use. Target patient populations include individuals with foot drop related to stroke, multiple sclerosis, traumatic brain injury, and spinal cord injury. The company operates a direct-to-consumer model with nationwide shipping, offers 30-day trial periods with 85% refund policy, and provides ongoing technical and clinical support at no additional cost beyond consumable electrodes. VA benefits are available through partnership with USVetServ. Two-year manufacturing warranty included. The device has FDA 510(k) clearance for USA use and is not yet available internationally.